Monitoring over time
When should tests be repeated?Monitor decisions, not numbers.
Repeat testing is useful when the result can change treatment, monitoring, referral or diagnosis. The right interval depends on the condition, medicine and test, not on a universal annual schedule.
Repeat a test when the answer can change the plan.
Repeat testing is useful when the result could change treatment, monitoring, referral or a diagnosis. It is less useful when the same result would lead to the same decision regardless of the number.
Intervals are condition-specific. NICE lipid guidance, for example, recommends a lipid profile and liver transaminases 2 to 3 months after starting or changing lipid-lowering treatment, then a different monitoring pattern once treatment is stable. [1] That schedule should not be copied to unrelated tests.
Before repeating any test, ask what is being monitored and what amount of change would be meaningful enough to alter care.
Why can repeating too soon be misleading?
Laboratory values vary because of normal biology, recent illness, hydration, time of day, meals, medicines and the test method. A small difference over a short interval may reflect normal variation rather than a true change in health.
Repeating too soon can also create a chain of borderline results. The next test should be timed to the biology of the condition, the medicine being monitored and the action that would follow.
If a result was unexpected, the right response may be confirmation, a different test or clinical review rather than simply ordering the same panel again.
Use four questions to decide whether another test is worthwhile.
First, what are we monitoring? Second, what change would be clinically meaningful? Third, when could that change realistically happen? Fourth, what would we do differently after the result?
These questions help separate necessary monitoring from repeated measurement that adds information without changing care.
Shared decision making also matters. NICE advises discussing the purpose, benefits, risks and alternatives of healthcare decisions, including the option of no change where appropriate. [2]
- Repeat because a guideline or treatment plan requires it.
- Repeat because a previous result needs confirmation.
- Repeat because symptoms or treatment have changed.
- Do not repeat only to chase a borderline number when no decision depends on it.
Who should own repeat testing?
The clinician responsible for the condition or medicine should usually make the monitoring plan clear. If several clinicians are involved, ask who orders the test, who reviews it and who acts on an abnormal result.
NICE multimorbidity guidance recommends agreeing who is responsible for coordination and arranging follow-up when care spans several conditions and services. [3]
The testing and diagnostics page explains the question-led approach used on this staging site.
What should you keep between tests?
Keep the full report, not only a highlighted portal value. Record the date, the laboratory, the reason for testing and any treatment changes made afterwards.
If you repeat the test, note whether the same method, timing or preparation matters. Comparable conditions make a trend easier to interpret.
Bring the earlier report to the next review. A trend can be more useful than a single value, but only when the clinician knows what changed between the measurements.
How to plan the next check
Write down the name of the test and the date it was done. Add the reason for the test. Then write what changed after the result. This gives the next review a clear starting point.
Ask when a real change could be expected. Some results can change in weeks. Others need months. A test done too soon may add noise rather than useful information.
Ask what value would change the plan. If the answer is 'none', another test may not be needed yet. If a change would affect a drug, referral or treatment, the timing should match that decision.
Keep the old report. Do not rely on memory. The units, lab range and exact value matter when a trend is reviewed.
A simple review note can prevent repeat work
Keep the old result, the date and the reason it was done. Add one sentence about what changed after it. Bring this note to the next review.
If nothing changed, ask whether another test is needed now. If treatment changed, ask when enough time has passed for the new test to be useful.
Keep the reason visible
A repeat test should answer a question. Write that question on the report. It will be easier to know when the next check is due.
What patients say about the consultation experience.
Patient reviews can help you understand how a consultation feels. They do not prove that a supplement, test or treatment is effective, and they do not predict a clinical outcome.
Individual reviews reflect personal experiences and do not predict diagnosis, treatment response or outcome.
“patient, understanding and kind”
Google reviewer
“warm and compassionate bedside manner”
Google reviewer
“takes incredible care to get to know her patients”
Google reviewer
Common questions
How often should blood tests be repeated?
There is no universal interval. The timing depends on the condition, medicine, test and the decision being monitored. Some guidelines specify intervals for particular treatments, while other tests are repeated only when symptoms, treatment or risk changes. Ask what the next result is meant to change.
Can repeating tests too often be harmful?
It can create cost, anxiety and extra follow-up from small or incidental changes that do not alter care. Repeated blood tests can also become burdensome. The right interval balances the chance of meaningful change against normal biological and laboratory variation.
Should an abnormal result always be repeated?
Not always. Some abnormal results need confirmation, while others are clear enough to require a different test, treatment or referral. The response depends on the test, degree of abnormality, symptoms and clinical context.
What if two results are slightly different?
Small differences can occur because of normal biological variation, timing, illness, hydration, medicines or laboratory method. Ask whether the change is larger than expected variation and whether it is large enough to change the clinical plan.
Who should arrange monitoring when I see several clinicians?
Ask which clinician owns each condition, medicine and test. The plan should state who orders repeat tests, who reviews results and who acts if something is abnormal. Clear responsibility helps prevent both duplicated testing and missed follow-up.
Can I ask not to repeat a test?
Yes. Ask what the repeat is for, what benefits and burdens it carries, and what happens if you do not do it now. A monitoring decision should be shared and linked to a clinical purpose rather than performed automatically.
Medical sources and further reading
- NICE NG238: Cardiovascular disease risk assessment and lipid modification. Provides examples of condition-specific repeat monitoring after starting or changing lipid-lowering treatment.
- NICE NG197: Shared decision making. Supports discussion of benefits, risks, alternatives and the option of no change.
- NICE NG56: Multimorbidity. Supports clear coordination, responsibility and individualised follow-up across multiple conditions and services.
A monitoring plan should have a purpose.
Know what is being followed, when change can occur and who is responsible for acting on the result.